Anti-Microbialvior BioteQ Co (ROCO:6864) NonCurrent Deferred Liabilities: NT$0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6864 Anti-Microbial Savior BioteQ Co Ltd ROCO:6864
60 GF Score
Price NT$41.45
GF Value NT$25.24
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Anti-Microbialvior BioteQ Co NonCurrent Deferred Liabilities?

Anti-Microbialvior BioteQ Co ROCO:6864 +0.36% 60 NonCurrent Deferred Liabilities is NT$0.00 Mil as of Dec. 2025. GuruFocus rates ROCO:6864 with a GF Score™ of 60/100 and a GF Value™ of NT$25.24 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Anti-Microbialvior BioteQ Co's non-current deferred liabilities for the quarter that ended in Dec. 2025 was NT$0.00 Mil.

Anti-Microbialvior BioteQ Co NonCurrent Deferred Liabilities Related Terms

Anti-Microbialvior BioteQ Co NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for Anti-Microbialvior BioteQ Co's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anti-Microbialvior BioteQ Co NonCurrent Deferred Liabilities Chart

Anti-Microbialvior BioteQ Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Anti-Microbialvior BioteQ Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ROCO:6864
60GF Score
Anti-Microbial Savior BioteQ Co Ltd ROCO:6864
NonCurrent Deferred Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Liabilities of NT$0.00 Mil mean?
Anti-Microbialvior BioteQ Co (ROCO:6864) has a NonCurrent Deferred Liabilities of NT$0.00 Mil as of Dec. 2025. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Anti-Microbialvior BioteQ Co and its competitors.
Is Anti-Microbialvior BioteQ Co's NonCurrent Deferred Liabilities too high?
Anti-Microbialvior BioteQ Co's current NonCurrent Deferred Liabilities is NT$0.00 Mil. Overall, Anti-Microbialvior BioteQ Co has a GF Score™ of 60/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Anti-Microbialvior BioteQ Co's NonCurrent Deferred Liabilities compare to VRTX and REGN?
Anti-Microbialvior BioteQ Co's NonCurrent Deferred Liabilities of NT$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Biotechnology company?
A good NonCurrent Deferred Liabilities depends on the Biotechnology industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Anti-Microbialvior BioteQ Co and its competitors. Anti-Microbialvior BioteQ Co's current NonCurrent Deferred Liabilities is NT$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anti-Microbialvior BioteQ Co stock overvalued right now?
Based on GuruFocus' analysis, Anti-Microbialvior BioteQ Co (ROCO:6864) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$25.24, compared to a current price of NT$41.45 — trading 64.2% above its estimated fair value. The current NonCurrent Deferred Liabilities is NT$0.00 Mil. Anti-Microbialvior BioteQ Co's overall GF Score™ is 60/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For Anti-Microbialvior BioteQ Co (ROCO:6864), the current NonCurrent Deferred Liabilities is NT$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Anti-Microbialvior BioteQ Co (ROCO:6864) Overvalued in 2026?

Based on GuruFocus' analysis, Anti-Microbialvior BioteQ Co stock appears to be overvalued. The current stock price of NT$41.45 is trading 64.2% above its estimated GF Value™ of NT$25.24. GuruFocus considers Anti-Microbialvior BioteQ Co to be Significantly Overvalued.

Key valuation signals for ROCO:6864:

  • NonCurrent Deferred Liabilities: NT$0.00 Mil
  • GF Value™: NT$25.24 vs. price of NT$41.45 (64.2% above fair value)
  • GF Score™: 60/100 with 3 warning signs

No single metric tells the full story. See the ROCO:6864 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Anti-Microbialvior BioteQ Co Business Description

Address No. 6, Siwei 3rd Road, 7th Floor-2, Lingya District, Kaohsiung, TWN, 741
Anti-Microbial Savior BioteQ Co Ltd is engaged in drug research and development as well as development and technology patenting of medical fungi.
60GF Score

Get the complete analysis for ROCO:6864

NonCurrent Deferred Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$41.45
Price
NT$25.24
GF Value